title: Complement activation and high-dose of interleukin-2.
authors.forename: L G
authors.initials: LG
authors.lastname: Thijs
authors.forename: C E
authors.initials: CE
authors.lastname: Hack
authors.forename: R J
authors.initials: RJ
authors.lastname: Strack van Schijndel
authors.forename: J H
authors.initials: JH
authors.lastname: Nuijens
authors.forename: G J
authors.initials: GJ
authors.lastname: Wolbink
authors.forename: A J
authors.initials: AJ
authors.lastname: Eerenberg-Belmer
authors.forename: H
authors.initials: H
authors.lastname: van der Vall
authors.forename: J
authors.initials: J
authors.lastname: Wagstaff
mesh_terms: D000328:Adult; D003167:Complement Activation / Q000187:drug effects*; D003176:Complement C3 / Q000032:analysis; D015926:Complement C3a; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008875:Middle Aged
chemical_list: D003176:Complement C3; D007376:Interleukin-2; D015926:Complement C3a